Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use

US11834547B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11834547-B2
Application numberUS-202117184716-A
CountryUS
Kind codeB2
Filing dateFeb 25, 2021
Priority dateJan 30, 2018
Publication dateDec 5, 2023
Grant dateDec 5, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are ophthalmic devices comprised of a reaction product of a composition comprising: (i) a crosslinked substrate network containing covalently bound activatable free radical initiators; and (ii) a grafting composition containing one or more ethylenically unsaturated compounds. Also provided are processes for making ophthalmic devices.

First claim

Opening claim text (preview).

We claim: 1. An ophthalmic device comprised of a reaction product of a composition comprising: (i) a crosslinked substrate network containing covalently bound monoacylphosphine oxide activatable free radical initiators; and (ii) a grafting composition containing one or more ethylenically unsaturated compounds. 2. The ophthalmic device of claim 1 wherein the grafting composition further comprises a crosslinker. 3. The ophthalmic device of claim 1 wherein the crosslinked substrate network is the reaction product of a first reactive composition comprising: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker. 4. The ophthalmic device of claim 1 wherein the one or more ethylenically unsaturated compounds in the grafting composition and the first reactive composition comprise polymerizable groups independently selected from: (meth)acrylate, (meth)acrylamide, styryl, vinyl, N-vinyl lactam, N-vinylamide, O-vinylether, O-vinylcarbonate, O-vinylcarbamate, C 2-12 alkenyl, C 2-12 alkenylphenyl, C 2-12 alkenylnaphthyl, and C 2-6 alkenylphenyl-C 1-6 alkyl. 5. The ophthalmic device of claim 1 wherein the crosslinked substrate network is formed from one or more silicone-containing components and the grafting composition contains hydrophilic reactive components. 6. The ophthalmic device of claim 1 wherein the crosslinked substrate network is formed from one or more hydrophilic reactive components and the grafting composition contains one or more silicone-containing components. 7. The ophthalmic device of claim 1 wherein the crosslinked substrate network is formed from one or more hydrophilic reactive components and the grafting composition contains hydrophilic reactive components. 8. The ophthalmic device of claim 1 wherein the crosslinked substrate network is formed from one or more silicone-containing components and the grafting composition contains one or more silicone-containing components. 9. The ophthalmic device of claim 1 wherein the crosslinked substrate network, the grafting composition, or both the crosslinked substrate network and the grafting composition contain one or more additives selected from UV absorbers, photochromic compounds, pharmaceutical compounds, nutraceutical compounds, antimicrobial compounds, tints, pigments, dyes, release agents, and wetting agents. 10. The ophthalmic device of claim 1 wherein the concentration of the grafting composition is greater at the crosslinked substrate network's surface than at its core. 11. The ophthalmic device of claim 1 that is selected from the group consisting of a contact lens, an intraocular lens, a punctal plug and an ocular insert.

Assignees

Inventors

Classifications

  • C08G18/61Primary

    Polysiloxanes · CPC title

  • Hydrating contact lenses · CPC title

  • enabling passage of fluids, e.g. oxygen, tears, between the area under the lens and the lens exterior · CPC title

  • Polysiloxanes · CPC title

  • with vinyl compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11834547B2 cover?
Provided are ophthalmic devices comprised of a reaction product of a composition comprising: (i) a crosslinked substrate network containing covalently bound activatable free radical initiators; and (ii) a grafting composition containing one or more ethylenically unsaturated compounds. Also provided are processes for making ophthalmic devices.
Who is the assignee on this patent?
Johnson & Johnson Vision Care
What technology area does this patent fall under?
Primary CPC classification C08G18/61. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).